Gujarat Themis Biosyn Publishes Newspaper Ad for Postal Ballot Notice
Gujarat Themis Biosyn Limited published its Postal Ballot Notice on January 8, 2026, in 'Western Times'. The notice seeks member approval for appointing Mr. Rajneesh Anand as a Non-Executive Non-Independent Director via e-voting. The voting period is from January 8 to February 6, 2026.
The announcement is a procedural step for director appointment and does not involve any immediate financial implications or significant business changes for the company. Therefore, the market impact is expected to be low.
The announcement is a routine regulatory filing regarding a postal ballot notice for director appointment. It does not contain significant financial or business updates that would positively or negatively impact the company's outlook.
Gujarat Themis Biosyn Limited announced the publication of its Postal Ballot Notice in the 'Western Times' (English and Gujarati editions) on Thursday, January 8, 2026. This publication is in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided copies of the newspaper articles as published for information and record.
The notice pertains to seeking member approval via remote electronic voting (e-voting) for the appointment of Mr. Rajneesh Anand as a Non-Executive Non-Independent Director. The e-voting facility, managed by CDSL, commenced on January 8, 2026, and will conclude on February 6, 2026. The cut-off date for determining voting rights was January 2, 2026. Mr. Ketan R. Shirwadkar has been appointed as the scrutinizer, and the results are expected to be announced by February 10, 2026.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.